The association of DNM2 defects with human disease has been previously identified in Charcot–Marie-Tooth peripheral neuropathy 24 and centronuclear myopathy 25–27, both of which involve DNM2 gene loss-of-function mutations. This evidence concerns the gene DNM2 and autosomal dominant centronuclear myopathy.